Clinical Trial Update: Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating inhaled pre-prandial human insulin for Type 2 diabetes was terminated, with reported findings on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled pre-prandial human insulin

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED